Phase II trial of gemcitabine and docetaxel in patients with completely resected stage IIA–IIIA non-small-cell lung cancer

By Kawamura Masafumi   Eguchi Keisuke   Izumi Yotaro   Yamato Yasushi   Koike Teruaki   Sakaguchi Hirozo   Hada Enjo   Kobayashi Koichi  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 4, 2007-09 ,pp. : 495-501

Springer Publishing Company

Access to resources Recommend Favorite

RNAi-mediated A disintegrin and metalloproteinase 9 gene silencing inhibits the tumor growth of non-small lung cancer in vitro and in vivo

By      

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 1197-1204

Spandidos Publications

Access to resources Recommend Favorite

Clinical significance of immunohistochemical expression of insulin-like growth factor-1 receptor and matrix metalloproteinase-7 in resected non-small cell lung cancer

By Yamamoto Taketsugu   Oshima Takashi   Yoshihara Kazue   Nishi Teppei   Arai Hiromasa   Inui Kenji   Kaneko Takeshi   Nozawa Akinori   Adachi Hiroyuki   Rino Yasushi   Masuda Munetaka   Imada Toshio  

Experimental and Therapeutic Medicine, Vol. 3, Iss. 5, 2012-05 ,pp. : 797-802

Spandidos Publications

Access to resources Recommend Favorite

Surveillance of resected non-small cell lung cancer

By López-González A.  

Clinical and Translational Oncology, Vol. 14, Iss. 10, 2012-10 ,pp. : 721-725

Springer Publishing Company

Access to resources Recommend Favorite

Expression of the copper transporters hCtr1, ATP7A and ATP7B is associated with the response to chemotherapy and survival time in patients with resected non-small cell lung cancer

By        

Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. : 2584-2590

Spandidos Publications

Access to resources Recommend Favorite